Number of Clinical Trials 2020
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #145
Samoa
- #144
Saint Kitts and Nevis
- #143
State of Palestine
- #142
Namibia
- #141
Martinique
- #140
Madagascar
- #139
Laos
- #138
Kyrgyzstan
- #137
Jamaica
- #136
Haiti
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Malawi
In 2020, Malawi ranked #73 globally with a total of 8 clinical trials. This figure is relatively low compared to regional peers, reflecting the challenges faced in attracting research investment in sub-Saharan Africa. Factors such as limited healthcare infrastructure, a small population, and economic constraints contribute to the country's current standing in clinical research.
France
In 2020, France ranked #2 globally with a total of 1284 clinical trials. This figure is significant, especially when compared to the global average, reflecting France's robust healthcare infrastructure and research capabilities. Key drivers include a strong emphasis on medical research and innovation, supported by government policies and funding initiatives aimed at enhancing clinical research in the country.
Ghana
In 2020, Ghana ranked #71 globally with a total of 8 clinical trials. This figure is notably lower than the regional average in West Africa, where countries like Nigeria lead with significantly higher numbers. The limited number of clinical trials in Ghana can be attributed to factors such as a developing healthcare infrastructure and the need for increased investment in research and development.
Canada
In 2020, Canada ranked #7 globally with a total of 592 clinical trials. This figure is notably higher than many countries in the region, reflecting Canada's robust healthcare infrastructure and reputation for high-quality research. Contributing factors include a diverse population that supports varied clinical research needs and government policies that encourage innovation in the health sector.
Algeria
In 2020, Algeria ranked #95 globally with a total of 3 clinical trials. This figure is notably lower than the regional average in North Africa, reflecting a limited capacity for clinical research compared to more advanced countries. Contributing factors include Algeria's economic constraints and a healthcare system that faces challenges in funding and infrastructure, which hinder the growth of clinical research initiatives.
Grenada
In 2020, Grenada had a global rank of #131 with a total of 1 clinical trial. This figure is significantly lower than many of its Caribbean neighbors, reflecting a regional trend where countries like Barbados and Jamaica host more extensive clinical research programs. Factors contributing to this low number include Grenada's small population, limited healthcare infrastructure, and a focus on tourism rather than medical research.
Bolivia
In 2020, Bolivia had a global rank of #103 with a total of 2 clinical trials. This figure is notably low compared to regional neighbors, as countries like Brazil and Argentina conduct significantly more trials, reflecting a broader trend in Latin America. Factors contributing to Bolivia's limited clinical trial activity include a smaller healthcare infrastructure, lower investment in research and development, and regulatory challenges that may hinder the establishment of clinical research initiatives.
Bangladesh
In 2020, Bangladesh ranked #50 globally with a total of 25 clinical trials. This figure is relatively low compared to leading countries in Asia, reflecting challenges in research funding and regulatory frameworks. The growth of clinical trials in Bangladesh is driven by a burgeoning pharmaceutical sector and increasing interest from international sponsors, which aim to leverage the country’s diverse population for clinical research.
Mongolia
Mongolia ranked #115 globally with a total of 2 clinical trials in 2020. This figure is notably low compared to more developed nations, which typically conduct hundreds or thousands of trials annually. The limited number of clinical trials in Mongolia can be attributed to factors such as a smaller population base, less investment in healthcare research, and challenges in regulatory frameworks that hinder clinical research initiatives.
Oman
In 2020, Oman ranked #116 globally with a total of 2 clinical trials. This number is notably low compared to regional peers, reflecting a limited clinical research infrastructure in the country. Key factors contributing to this situation include a smaller population and a developing healthcare sector that may not yet prioritize extensive clinical research initiatives.
Analysis & Context
In 2020, the United States led the world in the Number of Clinical Trials with a total of 6,220, while countries such as Albania, Armenia, and several others reported only 1 trial each. This data underscores a significant disparity in clinical research activities globally. The global average number of clinical trials was approximately 128.55, highlighting the vast differences in research capacity and focus among nations.
Global Leaders in Clinical Trials
The dominance of the United States in clinical trials is well-documented, with its robust healthcare infrastructure, significant investment in medical research, and a strong pharmaceutical industry. France and Turkey followed with 1,284 and 1,112 trials, respectively. These countries benefit from well-established healthcare systems and policies that encourage medical research and innovation. The presence of leading pharmaceutical companies and research institutions in these nations further contributes to their high number of clinical trials.
In contrast, countries like China and Egypt, with 967 and 840 trials respectively, have shown a growing focus on expanding their clinical research capabilities. China's increasing investment in healthcare and its large population provide a fertile ground for clinical trials, while Egypt's strategic location and growing healthcare sector are driving its research initiatives.
Explaining the Disparities
Several factors contribute to the disparities in the number of clinical trials across countries. Economic capacity is a primary driver; wealthier nations tend to invest more in healthcare and research. For instance, Germany and Canada, with 537 and 592 trials respectively, leverage their economic strengths to support extensive medical research activities.
Geopolitical stability and regulatory environments also play crucial roles. Countries with stable governments and clear regulatory frameworks, such as the United Kingdom and Italy, are more attractive to researchers and pharmaceutical companies. The UK conducted 629 trials, benefiting from its historical emphasis on medical research and innovation.
In contrast, nations with fewer trials, like Bahrain and Comoros, often face challenges such as limited funding, smaller populations, and less developed healthcare infrastructures, which can hinder their ability to conduct extensive clinical research.
Year-over-Year Trends and Changes
The year-over-year changes in clinical trial numbers provide further insights into global research dynamics. The United States experienced a decrease of 575 trials, an 8.5% drop, which may be attributed to shifts in research priorities or the impacts of global events such as the COVID-19 pandemic. Similarly, the United Kingdom and Canada saw declines of 144 and 118 trials, respectively.
Conversely, Egypt and Turkey recorded significant increases in their clinical trial numbers, with rises of 218 and 205 trials, respectively. These gains reflect their strategic efforts to enhance medical research capabilities and attract international research collaborations. Pakistan, with a remarkable 74.5% increase, added 105 trials, signaling a growing commitment to developing its healthcare research infrastructure.
Implications for Global Health Research
The distribution of clinical trials globally has profound implications for medical research and innovation. Countries with higher numbers of trials are likely to lead in advancements in medical treatments and technologies. This leadership can translate into improved health outcomes and economic benefits. However, the disparity in trial numbers also highlights the need for increased support and collaboration to bolster research capabilities in underrepresented regions.
Efforts to address these imbalances could include international partnerships, investment in healthcare infrastructure, and policy reforms that encourage research activities. By fostering a more equitable landscape for clinical trials, the global community can enhance its collective capacity to respond to emerging health challenges and promote innovation across borders.
Frequently Asked Questions About Number of Clinical Trials in 2020
Which country conducted the most clinical trials in 2020?
The United States conducted the most clinical trials in 2020, with a total of 6,220 trials.
Which country conducted the fewest clinical trials in 2020?
Albania conducted the fewest clinical trials in 2020, with only 1 trial.
What was the average number of clinical trials conducted by countries in 2020?
The average number of clinical trials conducted by countries in 2020 was 129.
What was the median number of clinical trials conducted by countries in 2020?
The median number of clinical trials conducted by countries in 2020 was 8.
Which countries were in the top 10 for the number of clinical trials in 2020?
The top 10 countries for the number of clinical trials in 2020 were the United States, France, Turkey, China, Egypt, United Kingdom, Canada, Germany, Spain, and Italy.
How many countries conducted only 1 clinical trial in 2020?
Ten countries conducted only 1 clinical trial in 2020, including Albania, Armenia, Bahrain, Comoros, Samoa, Saint Kitts and Nevis, Côte d'Ivoire, Eswatini, Faroe Islands, and French Guiana.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2020. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2020
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.